Mass spectrometric assay and physiological-pharmacological activity of androgenic neurosteroids

Neurochemistry International

Volumn 52, Issue 4-5, 2008, Pages 541-553

  Reddy, Doodipala S ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

17 Estradiol; 3 Androstanediol; Epilepsy; GABAA receptor; Hippocampus; Mass spectrometry; Neurosteroid; Seizure susceptibility; Testosterone

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; ANASTROZOLE; ANDROGEN; ANDROSTANE DERIVATIVE; ANDROSTANEDIOL; ANDROSTANOLONE; AROMATASE INHIBITOR; ESTRADIOL; FINASTERIDE; INDOMETACIN; KAINIC ACID; LETROZOLE; NEUROSTEROID; PENTETRAZOLE; PILOCARPINE; STEROID; STEROID 5ALPHA REDUCTASE INHIBITOR; TESTOLACTONE; TESTOSTERONE;

ADJUVANT THERAPY; ANTICONVULSANT ACTIVITY; ARTICLE; BIOSYNTHESIS; CHEMICAL STRUCTURE; DISEASE PREDISPOSITION; DRUG ACTIVITY; DRUG RESEARCH; ENZYME INHIBITION; EPILEPSY; EXPERIMENTAL MODEL; HUMAN; MASS SPECTROMETRY; NERVE CELL EXCITABILITY; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; SEIZURE; STEROID BLOOD LEVEL; TESTOSTERONE METABOLISM;

ANDROGENS; ANDROSTANE-3,17-DIOL; ANIMALS; AROMATASE INHIBITORS; ESTROGENS; HUMANS; MASS SPECTROMETRY; NEUROTRANSMITTER AGENTS; RECEPTORS, GABA-A; STEROIDS; TESTOSTERONE;

EID: 38349187871     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2007.05.019     Document Type: Article

References (126)

1. Azzolina B., Ellsworth K., Andersson S., Geissler W., Bull H.G., and Harris G.S. Inhibition of rat 5α-reductases by finasteride: evidence for isozyme differences in the mechanism of inhibition. J. Steroid Biochem. Mol. Biol. 61 (1997) 55-64
2. Bäckström T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol. Scand. 54 (1976) 321-347
3. Bauer J., Stoffel-Wagner B., Flugel D., Kluge M., Schramm J., Bidlingmaier F., and Elger C.E. Serum androgens return to normal after temporal lobe epilepsy surgery in men. Neurology 55 (2000) 820-824
4. Belelli D., Bolger M.B., and Gee K.W. Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Eur. J. Pharmacol. 166 (1989) 325-329
5. Beyenburg S., Stoffel-Wagner B., Watzka M., Blumcke I., Bauer J., Schramm J., Bidlingmaier F., and Elger C.E. Expression of cytochrome P450scc mRNA in the hippocampus of patients with temporal lobe epilepsy. Neuroreport 10 (1999) 3067-3070
6. Bhatnagar A.S., Brodie A.M., Long B.J., Evans D.B., and Miller W.R. Intracellular aromatase and its relevance to the pharmacological efficacy of aromatase inhibitors. J. Steroid Biochem. Mol. Biol. 76 (2001) 199-202
7. Bhatnagar A.S., Hausler A., Schieweck K., Lang M., and Bowman R. Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor. J. Steroid Biochem. Mol. Biol. 37 (1990) 1021-1027
8. Bicikova M., Lapcik O., Hampl R., Starka L., Knuppen R., Haupt O., and Dibbelt L. A novel radioimmunoassay of allopregnanolone. Steroids 60 (1995) 210-213
9. Bixo M., Andersson A., Winblad B., Purdy R.H., and Backstrom T. Progesterone, 5alpha-pregnane-3,20-dione and 3alpha-hydroxy-5alpha-pregnane-20-one in specific regions of the human female brain in different endocrine states. Brain Res. 764 (1997) 173-178
10. Buterbaugh G.G. Estradiol replacement facilitates the acquisition of seizures kindled from the anterior neocortex in female rats. Epilepsy Res. 4 (1989) 207-215
11. Chatman K., Hollenbeck T., Hagey L., Vallee M., Purdy R., Weiss F., and Siuzdak G. Nanoelectrospray mass spectrometry and precursor ion monitoring for quantitative steroid analysis and attomole sensitivity. Anal. Chem. 71 (1999) 2358-2363
12. Cheney D.L., Uzunov D., Costa E., and Guidotti A. Gas chromatography-mass fragentation quantification of 3α-hydroxy-5α-pregnan-20-one (allopregnanone) and its precursor in blood and brain of adrenalectomized and castrated rats. J. Neurosci. 16 (1995) 4641-4650
13. Cooke B.M., Tabibnia G., and Breedlove S.M. A brain sexual dimorphism controlled by adult circulating androgens. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 7538-7540
14. Cunningham G.R., Tindall D.J., and Means A.R. Differences in steroid specificity for rat androgen binding protein and the cytoplasmic receptor. Steroids 33 (1979) 261-276
15. Dong E., Matsumoto K., Uzunova V., Sugaya I., Takahata H., Nomura H., Watanabe H., Costa E., and Guidotti A. Brain 5α-dihydroprogesterone and allopregnanolone synthesis in a mouse model of protracted social isolation. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 2849-2854
16. Duncan S., Blacklaw J., Beastall G.H., and Brodie M.J. Antiepileptic drug therapy and sexual function in men with epilepsy. Epilepsia 40 (1999) 197-204
17. Edwards H.E., Burnham W.M., and MacLusky N.J. Testosterone and its metabolites affect afterdischarge thresholds and the development of amygdala kindled seizures. Brain Res. 838 (1999) 151-157
18. Edwards H.E., Mo V., Burnham W.M., and MacLusky N.J. Gonadectomy unmasks an inhibitory effect of progesterone on amygdala kindling in male rats. Brain Res. 889 (2001) 260-263
19. El-Khayat H.A., Shatla H.M., Ali G.K., Abdulgani M.O., Tomoum H.Y., and Attya H.A. Physical and hormonal profile of male sexual development in epilepsy. Epilepsia 44 (2003) 447-452
20. Fredline V.F., Taylor P.J., Dodds H.M., and Johnson A.G. A reference method for the analysis of aldosterone in blood by high-performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry. Anal. Biochem. 252 (1997) 308-313
21. Frye C.A., Van Keuren K.R., and Erskine M.S. Behavioral effects of 3α-androstanediol. I: Modulation of sexual receptivity and promotion of GABA-stimulated chloride flux. Behav. Brain Res. 79 (1996) 109-118
22. Frye C.A., and Reed T.A. Androgenic neurosteroids: anti-seizure effects in an animal model of epilepsy. Psychoneuroendocrinology 23 (1998) 385-399
23. Frye C.A., Edinger K.L., Seliga A.M., and Wawrzycki J.M. 5α-Reduced androgens may have actions in the hippocampus to enhance cognitive performance of male rats. Psychoneuroendocrinology 29 (2004) 1019-1027
24. Frye C.A., Rhodes M.E., Walf A.A., and Harney J.P. Testosterone reduces pentylenetetrazole-induced ictal activity of wildtype mice but not those deficient in type I 5α-reductase. Brain Res. 918 (2001) 182-186
25. Frye C.A., Park D., Tanaka M., Rosellini R., and Svare B. The testosterone metabolite and neurosteroid 3α-androstanediol may mediate the effects of testosterone on conditioned place preference. Psychoneuroendocrinology 26 (2001) 731-750
26. Gee K.W., Bolger M.B., Brinton R.E., Coirini H., and McEwen B.S. Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action. J. Pharmacol. Exp. Ther. 246 (1988) 803-812
27. Griffiths W.J., Liu S., Yang Y., Purdy R.H., and Sjovall J. Nano-electrospray tandem mass spectrometry for the analysis of neurosteroid sulphates. Rapid Commun. Mass Spectrom. 13 (1999) 1595-1610
28. Grigorian V.Z., and Khudaverkian D.N. Effect of castration and subsequent administration of testosterone propionate on susceptibility to convulsions in animals. Zh. Eksp. Klin. Med. 10 (1970) 11-17
29. Harden C., and MacLusky N.J. Aromatase inhibition, testosterone, and seizures. Epilepsy Behav. 5 (2004) 260-263
30. Harden C.L., Nikolov B.G., Labar D.L., and MacLusky N.J. Aromatase inhibitors as Add-on treatment for men with epilepsy. Neurology 62 Suppl. 5 (2004) 118-119
31. Harden C.L., and MacLusky N.J. Aromatase inhibitors as add-on treatment for men with epilepsy. Expert Rev. Neurother. 5 (2005) 123-127
32. Harrison N.L., Majewska M.D., Harrington J.W., and Barker J.L. Structure-activity relationships for steroid interactions with the γ-aminobutyric acid-A receptor complex. J. Pharmacol. Exp. Ther. 241 (1987) 346-353
33. Herzog A.G. Reproductive endocrine considerations and hormonal therapy for men with epilepsy. Epilepsia 32 Suppl. 6 (1991) S34-S37
34. Herzog A.G. Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology 45 (1995) 1660-1662
35. Herzog A.G., Klein P., and Jacobs A.R. Testosterone versus testosterone and testolactone in treating reproductive and sexual dysfunction in men with epilepsy and hypogonadism. Neurology 50 (1998) 782-784
36. Herzog A.G., and Frye C.A. Seizure exacerbation associated with inhibition of progesterone metabolism. Ann. Neurol. 53 (2003) 390-391
37. Herzog A.G., Drislane F.W., Schomer D.L., Pennell P.B., Bromfield E.B., Dworetzky B.A., Farina E.L., and Frye C.A. Differential effects of antiepileptic drugs on neuroactive steroids in men with epilepsy. Epilepsia 47 11 (2006) 1945-1948
38. Higashi T., Takido N., and Shimada K. Studies on neurosteroids XVII. Analysis of stress-induced changes in neurosteroid levels in rat brains using liquid chromatography-electron capture atmospheric pressure chemical ionization-mass spectrometry. Steroids 70 (2005) 1-11
39. Holloway C.C., and Clayton D.E. Estrogen synthesis in the male brain triggers development of the avian song control pathway in vitro. Nat. Neurosci. 4 (2001) 170-175
40. Hom A.C., and Buterbaugh G.G. Estrogen alters the acquisition of seizures kindled by repeated amygdala stimulation or pentylenetetrazol administration in ovariectomized female rats. Epilepsia 27 (1986) 103-108
41. Inoue T., Akahira J., Suzuki T., Darnel A.D., Kaneko C., Takahashi K., Hatori M., Shirane R., Kumabe T., Kurokawa Y., Satomi S., and Sasano H. Progesterone production and actions in the human central nervous system and neurogenic tumors. J. Clin. Endocrinol. Metab. 87 (2002) 5325-5331
42. Isojarvi J.I., Pakarinen A.J., and Myllyla V.V. Effects of carbamazepine therapy on serum sex hormone levels in male patients with epilepsy. Epilepsia 29 (1988) 781-786
43. Jin Y., and Penning T.M. Steroid 5α-reductases and 3α-hydroxysteroid dehydrogenases: key enzymes in androgen metabolism. Baillieres Best Pract. Res. Clin. Endocrinol. Metab. 15 (2001) 79-94
44. Joels M. Steroid hormones and excitability in the mammalian brain. Front Neuroendocrinol. 18 (1997) 2-48
45. Joh H.D., Searles R.V., Selmanoff M., Alkayed N.J., Koehler R.C., Hurn P.D., and Murphy S.J. Estradiol alters only GAD67 mRNA levels in ischemic rat brain with no consequent effects on GABA. J. Cereb. Blood Flow Metab. 26 (2006) 518-526
46. Kaminski R.M., Livingood M.R., and Rogawski M.A. Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice. Epilepsia 45 (2004) 864-867
47. Kaminski R.M., Marini H., Kim W.J., and Rogawski M.A. Anticonvulsant activity of androsterone and etiocholanolone. Epilepsia 46 (2005) 819-827
48. A receptors. J. Pharmacol. Exp. Ther. 317 (2006) 694-703
49. Kim Y.-S., Zhang H., and Kim H.-Y. Profiling neurosteroids in cerebrospinal fluids and plasma by gas chromatography/electron capture negative chemical ionization mass spectrometry. Anal. Biochem. 277 (2000) 187-195
50. Kobayashi Y., Saiki K., and Watanabe F. Characteristics of mass fragmentation of steroids by atmospheric pressure chemical ionization-mass spectrometry. Biol. Pharm. Bull. 16 (1993) 1175-1178
51. Kokate T.G., Svensson B.E., and Rogawski M.A. Anticonvulsant activity of neurosteroids: correlation with γ-aminobutyric acid-evoked chloride current potentiation. J. Pharmacol. Exp. Ther. 270 (1994) 1223-1229
52. A receptors by endogenous and synthetic neuroactive steroids. Brain Res. Rev. 37 (2001) 68-80
53. Lanthier A., and Patwardhan V.V. Sex steroids and 5-en-3 beta-hydroxysteroids in specific regions of the human brain and cranial nerves. J. Steroid Biochem. 25 (1986) 445-449
54. Lierre P., Akwa Y., Weill-Engerer S., Eychenne B., Pianos A., Robel P., Sjovall J., Schumacher M., and Baulieu E.-E. Validation of an analytical procedure to measure trace amounts of neurosteroids in brain tissue by gas chromatography-mass spectrometry. J. Chromatogr. B 739 (2000) 301-312
55. MacLusky N.J., Walters M.J., Clark A.S., and Toran-Allerand C.D. Aromatase in the cerebral cortex, hippocampus, and mid-brain: ontogeny and developmental implications. Mol. Cell. Neurosci. 5 (1994) 691-698
56. Macphee G.J., Larkin J.G., Butler E., Beastall G.H., and Brodie M.J. Circulating hormones and pituitary responsiveness in young epileptic men receiving long-term antiepileptic medication. Epilepsia 29 (1988) 468-475
57. Mahendroo M.S., Cala K.M., and Russell D.W. 5α-Reduced androgens play a key role in murine parturition. Mol. Endocrinol. 10 (1996) 380-392
58. Mahendroo M.S., Cala K.M., Landrum D.P., and Russell D.W. Fetal death in mice lacking 5α-reductase type 1 caused by estrogen excess. Mol. Endocrinol. 11 (1997) 917-927
59. Martini L. Androgen metabolism in the brain. Neuroendocrinol. Lett. 14 (1992) 315-318
60. Martini L., Melcangi R.C., and Maggi R. Androgen and progesterone metabolism in the central and peripheral nervous system. J. Steroid Biochem. Mol. Biol. 47 (1993) 195-205
61. A receptors. Brain Res. Rev. 29 (1999) 196-217
62. Mejias-Aponte C.A., Jimenez-Rivera C.A., and Segarra A.C. Sex differences in models of temporal lobe epilepsy: role of testosterone. Brain Res. 944 (2002) 210-218
63. Mensah-Nyagan A.G., Do-Rego J.L., Beaujean D., Luu-The V., Pelletier G., and Vaudry H. Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. Pharmacol. Rev. 51 (1999) 63-81
64. Meyer R.P., Hagemeyer C.E., Knoth R., Kaufmann M.R., and Volk B. Anti-epileptic drug phenytoin enhances androgen metabolism and androgen receptor expression in murine hippocampus. J. Neurochem. 96 (2006) 460-472
65. Morfin R., Young J., Corpechot C., Egestad B., Sjovall J., and Baulieu E.E. Neurosteroids: pregnenolone in human sciatic nerves. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 6790-6793
66. Monteleone P., Luisi S., Tonetti A., Bernardi F., Genazzani A.D., Luisi M., Petraglia F., and Genazzani A.R. Allopregnanolone concentrations and premenstrual syndrome. Eur. J. Endocrinol. 142 (2000) 269-273
67. Murphy D.D., Cole N.B., Greenberger V., and Segal M. Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons. J. Neurosci. 18 (1998) 2550-2559
68. Nakamura N.H., Rosell D.R., Akama K.T., and McEwen B.S. Estrogen and ovariectomy regulate mRNA and protein of glutamic acid decarboxylases and cation-chloride cotransporters in the adult rat hippocampus. Neuroendocrinology 80 (2004) 308-323
69. Neri R. Pharmacology and pharmacokinetics of flutamide. Urology 34 Suppl. 4 (1989) 19-21
70. Nicoletti F., Speciale C., Sortino M.A., Summa G., Caruso G., Patti F., and Canonico P.L. Comparative effects of estradiol benzoate, the antiestrogen clomiphene citrate, and the progestin medroxyprogesterone acetate on kainic acid-induced seizures in male and female rats. Epilepsia 26 (1985) 252-257
71. A receptor function through distinct sites. Brain Res. 830 (1999) 72-87
72. Penning T.M., Sharp R.B., and Kriegers N.R. Purification and properties of 3α-hydroxysteroid hydrogenase from rat brain cytosol. J. Biol. Chem. 260 (1985) 15266-15282
73. Penning T.M., and Talalay P. Inhibition of a major NAD(P)-linked oxidoreductase from rat liver cytosol by steroidal and nonsteroidal anti-inflammatory agents and by prostaglandins. Proc. Natl. Acad. Sci. U.S.A. 80 (1983) 4504-4508
74. Pericic D., Manev H., and Bujas M. Gonadal hormones and picrotoxin-induced convulsions in male and female rats. Brain Res. 736 (1996) 174-179
75. Pesce M.E., Acevedo X., Bustamante D., Miranda H.E., and Pinardi G. Progesterone and testosterone modulate the convulsant actions of pentylenetetrazol and strychnine in mice. Pharmacol. Toxicol. 87 (2000) 116-119
76. Pinna G., Costa E., and Guidotti A. Changes in brain testosterone and allopregnanolone biosynthesis elicit aggressive behavior. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 2135-2140
77. Purdy R.H., Moore P.H., Rao P.N., Hagino N., Yamaguchi T., Schmidt P., Rubinow D.R., Morrow A.L., and Paul S.M. Radioimmunoassay of 3α-hydroxy-5α-pregnan-20-one in rat and human plasma. Steroids 55 (1990) 290-296
78. Purdy R.H., Morrow A.L., Moore Jr. P.H., and Paul S.M. Stress-induced elevations of γ-aminobutyric acid type A receptor-active steroids in the rat brain. PNAS 88 (1991) 4553-4557
79. Ramu K., Lam G.N., and Chien B. A high-performance liquid chromatography-tandem mass spectrometric method for the determination of pharmacokinetics of ganaxolone in rat, monkey, dog and human plasma. J. Chromatogr. 751 (2001) 49-59
80. Ravizza T., Friedman L.K., Moshe S.L., and Veliskova J. Sex differences in GABAergic system in rat substantia nigra pars reticulate. Int. J. Dev. Neurosci. 21 (2003) 245-254
81. Reddy D.S., and Kulkarni S.K. Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice. Brain Res. 752 (1997) 61-71
82. Reddy D.S., Kim H.-Y., and Rogawski M.A. Neurosteroid withdrawal model of perimenstrual catamenial epilepsy. Epilepsia 42 (2001) 328-336
83. A receptor function and seizure susceptibility. J. Neurosci. 22 (2002) 3795-3805
84. Reddy D.S. Is there a physiological role for the neurosteroid THDOC in the stress-sensitive conditions?. Trends Pharmacol. Sci. 24 (2003) 103-106
85. Reddy D.S. Pharmacology of endogenous neuroactive steroids. Crit. Rev. Neurobiol. 15 (2003) 197-234
86. Reddy D.S. Role of neurosteroids in catamenial epilepsy. Epilepsy Res. 62 (2004) 99-118
87. Reddy D.S. Anticonvulsant activity of the testosterone-derived neurosteroid 3α-androstanediol. Neuroreport 15 (2004) 515-518
88. Reddy D.S. Testosterone modulation of seizure susceptibility is mediated by neurosteroids 17β-estradiol and 3α-androstanediol. Neuroscience 129 (2004) 195-207
89. Reddy D.S., Castaneda D.C., O'Malley B.W., and Rogawski M.A. Anticonvulsant activity of progesterone and neurosteroids in progesterone receptor knockout mice. J. Pharmacol. Exp. Ther. 310 (2004) 230-239
90. Reddy D.S. Pharmacotherapy of catamenial epilepsy. Ind. J. Pharmacol. 37 (2005) 288-293
91. Reddy D.S., O'Malley B.W., and Rogawski M.A. Anxiolytic activity of progesterone in progesterone receptor knockout mice. Neuropharmacology 48 (2005) 4-24
92. Reddy D.S., Chien B., and Ramu K. A high-performance liquid chromatography-tandem mass spectrometry assay of the androgenic neurosteroid 3α-androstanediol (5α-androstan-3α, 17β-diol) in plasma. Steroids 70 (2005) 879-885
93. Reddy D.S. Physiological role of adrenal deoxycorticosterone-derived neuroactive steroids in stress-sensitive conditions. Neuroscience 138 (2006) 911-920
94. Rogawski M.A., and Reddy D.S. Neurosteroids: endogenous modulators of seizure susceptibility. In: Rho J.M., Sankar R., and Cavazos J. (Eds). Epilepsy: Scientific Foundations of Clinical Treatment (2004), Marcel Dekker, New York 319-355
95. Roselli C.E., Horton L.E., and Resko J.A. Time-course and steroid specificity of aromatase induction in rat hypothalamus-preoptic area. Biol. Reprod. 37 (1987) 628-633
96. Rosse R.B., Mastropaolo J., Novitzki M.R., and Deutsch S.I. Depot testosterone attenuates the anticonvulsant effect of flurazepam in mice. Psychoneuroendocrinology 15 (1990) 83-85
97. Rudick C.N., and Woolley C.S. Estrogen regulates functional inhibition of hippocampal CA1 pyramidal cells in the adult female rat. J. Neurosci. 21 (2001) 6532-6543
98. Saberi M., and Pourgholami M.H. Estradiol alters afterdischarge threshold and acquisition of amygdala kindled seizures in male rats. Neurosci. Lett. 340 (2003) 41-44
99. Schieweck K., Bhatnagar A.S., Batzl C., and Lang M. Anti-tumor and endocrine effects of non-steroidal aromatase inhibitors on estrogen-dependent rat mammary tumors. J. Steroid Biochem. Mol. Biol. 44 (1993) 633-636
100. Schumacher M., Weill-Engerer S., Liere P., Robert F., Franklin R.J., Garcia-Segura L.M., Lambert J.J., Mayo W., Melcangi R.C., Parducz A., Suter U., Carelli C., Baulieu E.E., and Akwa Y. Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog. Neurobiol. 71 (2003) 3-29
101. Schwartz-Giblin S., Korotzer A., and Pfaff D.W. Steroid hormone effects on picrotoxin-induced seizures in female and male rats. Brain Res. 476 (1989) 240-247
102. Smith S.S., Waterhouse B.D., and Woodward D.J. Locally applied estrogens potentiate glutamate-evoked excitation of cerebellar Purkinje cells. Brain Res. 475 (1988) 272-282
103. A receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 392 (1998) 926-930
104. Stoffel-Wagner B. Neurosteroid biosynthesis in the human brain and its clinical implications. Ann. N.Y. Acad. Sci. 1007 (2003) 64-78
105. Stoffel-Wagner B., Watzka M., Steckelbroeck S., Ludwig M., Clusmann H., Bidlingmaier F., Casarosa E., Luisi S., Elger C.E., and Beyenburg S. Allopregnanolone serum levels and expression of 5 α-reductase and 3α-hydroxysteroid dehydrogenase isoforms in hippocampal and temporal cortex of patients with epilepsy. Epilepsy Res. 54 (2003) 11-19
106. Tauboll E., Lindstrom S., and Gjerstad L. Acute effects of 17β-estradiol on brain excitability studied in vitro and in vivo. Epilepsy Res. 18 (1994) 107-117
107. Thigpen A.E., and Russell D.W. Four-amino acid segment in steroid 5α-reductase 1 confers sensitivity to finasteride, a competitive inhibitor. J. Biol. Chem. 267 (1992) 8577-8583
108. Thomas J., and McLean J.H. Castration alters susceptibility of male rats to specific seizures. Physiol. Behav. 49 (1991) 1177-1179
109. Thomas J., and Yang Y.C. Allylglycine-induced seizures in male and female rats. Physiol. Behav. 49 (1991) 1181-1183
110. Vallee M., Rivera J.D., Koob G.F., Purdy R.H., and Fitzgerald R.L. Quantification of neurosteroids in rat plasma and brain following swim stress and allopregnanolone administration using negative chemical ionization gas chromatography/mass spectrometry. Anal. Biochem. 287 (2000) 153-166
111. Veliskova J. The role of estrogens in seizures and epilepsy: the bad guys or the good guys?. Neuroscience 138 (2006) 837-844
112. VMDB Report. 2003. Search terms "epilepsy" in intact versus castrated dogs. The Veterinary Medical Database (www.vmdb.org).
113. Volmer D.A., and Hui J.P. Rapid determination of corticosteroids in urine by combined solid phase microextraction/liquid chromatography/mass spectrometry. Rapid Commun. Mass Spectrom. 11 (1997) 1926-1933
114. Watzka M., Bidlingmaier F., Schramm J., Klingmuller D., and Stoffel-Wagner B. Sex- and age-specific differences in human brain CYP11A1 mRNA expression. J. Neuroendocrinol. 11 (1999) 901-905
115. Weiland N.G. Glutamic acid decarboxylase messenger ribonucleic acid is regulated by estradiol and progesterone in the hippocampus. Endocrinology 131 (1992) 2697-2702
116. Werboff L.H., and Havlena J. Audiogenic seizures in adult male rats treated with various hormones. Gen. Comp. Endocrinol. 3 (1968) 389-397
117. Wong M., and Moss R.L. Electrophysiological evidence for a rapid membrane action of the gonadal steroid, 17β-estradiol, on CA1 pyramidal neurons of the rat hippocampus. Brain Res. 543 (1991) 148-152
118. Wong M., and Moss R.L. Patch-clamp analysis of direct steroidal modulation of glutamate receptor-channels. J. Neuroendocrinol. 6 (1994) 347-355
119. Woolley C.S., Weiland N.G., McEwen B.S., and Schwartzkroin P.A. Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J. Neurosci. 17 (1997) 1848-1859
120. Woolley C.S. Estradiol facilitates kainic acid-induced, but not flurothyl-induced, behavioral seizure activity in adult female rats. Epilepsia 41 (2000) 510-515
121. Woolley D.E., Timiras P.S., Rosenzweig M.R., Krech D., and Bennett E.L. Sex and strain differences in electroshock convulsions of the rat. Nature 190 (1961) 156-515
122. Wudy S.A., Dorr H.G., Solleder C., Djalali M., and Homoki J. Profiling steroid hormones in amniotic fluid of midpregnancy by routine stable isotope dilution/gas chromatography-mass spectrometry: reference values and concentrations in fetuses at risk for 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 84 (1999) 2724-2728
123. Yu L., Romero D.G., Gomez-Sanchez C.E., and Gomez-Sanchez E.P. Steroidogenic enzyme gene expression in the human brain. Mol. Cell. Endocrinol. 190 (2002) 9-17
124. A receptors. Exp. Neurol. 203 (2007) 72-81
125. Zhao M., Baker S.D., Yan X., Zhao Y., Wright W.W., Zirkin B.R., and Jarow J.P. Simultaneous determination of steroid composition of human testicular fluid using liquid chromatography tandem mass spectrometry. Steroids 69 (2004) 721-726
126. Zwain I.H., and Yen S.S. Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain. Endocrinology 140 (1999) 3843-3852